25 XP   0   0   10

Guangdong Jiaying Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Guangdong Jiaying Pharmaceutical Co Ltd together

PenkeI guess you are interested in Guangdong Jiaying Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangdong Jiaying Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangdong Jiaying Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guangdong Jiaying Pharmaceutical Co Ltd.

Quick analysis of Guangdong Jiaying Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Guangdong Jiaying Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
67.5%

What is your share worth?

Current worth
¥1.48
Expected worth in 1 year
¥1.57
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
¥0.09
Return On Investment
1.4%

For what price can you sell your share?

Current Price per Share
¥6.53
Expected price per share
¥4.83 - ¥7.04
How sure are you?
50%

1. Valuation of Guangdong Jiaying Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.53

Intrinsic Value Per Share

¥0.68 - ¥0.76

Total Value Per Share

¥2.16 - ¥2.25

2. Growth of Guangdong Jiaying Pharmaceutical Co Ltd (5 min.)




Is Guangdong Jiaying Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$104m$95.8m$6.7m6.6%

How much money is Guangdong Jiaying Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.6m$665.7k$945.9k58.7%
Net Profit Margin7.2%3.3%--

How much money comes from the company's main activities?

3. Financial Health of Guangdong Jiaying Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Guangdong Jiaying Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Guangdong Jiaying Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Guangdong Jiaying Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Guangdong Jiaying Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Guangdong Jiaying Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guangdong Jiaying Pharmaceutical Co Ltd is ¥6.53. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangdong Jiaying Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangdong Jiaying Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.48. Based on the TTM, the Book Value Change Per Share is ¥0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangdong Jiaying Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%
Usd Price Per Share0.96-1.05-0.86-0.89-1.20-
Price to Earnings Ratio132.26-109.81-40.58-219.38-193.02-
Price-to-Total Gains Ratio529.05-503.60-106.87-626.92-461.65-
Price to Book Ratio4.69-5.17-4.58-4.57-5.41-
Price-to-Total Gains Ratio529.05-503.60-106.87-626.92-461.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.903752
Number of shares1106
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1106 shares)3.40-0.11
Gains per Year (1106 shares)13.58-0.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101440-1-10
2027181-2-10
3041321-3-10
4054462-4-10
5068602-5-10
6081743-5-10
7095883-6-10
801091024-7-10
901221164-8-10
1001361305-9-10

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%35.04.01.087.5%58.04.03.089.2%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%33.07.00.082.5%53.012.00.081.5%
Dividend per Share0.00.04.00.0%7.00.05.058.3%15.00.05.075.0%27.00.013.067.5%45.00.020.069.2%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%34.06.00.085.0%55.010.00.084.6%

Fundamentals of Guangdong Jiaying Pharmaceutical Co Ltd

About Guangdong Jiaying Pharmaceutical Co Ltd

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patient medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also offers provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufenghuoluo tablets, Tiaomenghuoxue tablets, and etc. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meizhou, China.

Fundamental data was last updated by Penke on 2024-03-23 23:33:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Guangdong Jiaying Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guangdong Jiaying Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangdong Jiaying Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 5.6% means that ¥0.06 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 5.6%. The company is making a profit. +1
  • The TTM is 7.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.6%TTM7.2%-1.6%
TTM7.2%YOY3.3%+3.8%
TTM7.2%5Y-0.2%+7.3%
5Y-0.2%10Y6.7%-6.9%
1.1.2. Return on Assets

Shows how efficient Guangdong Jiaying Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangdong Jiaying Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 0.8% Return on Assets means that Guangdong Jiaying Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.4%-0.6%
TTM1.4%YOY0.6%+0.8%
TTM1.4%5Y-0.1%+1.5%
5Y-0.1%10Y0.9%-0.9%
1.1.3. Return on Equity

Shows how efficient Guangdong Jiaying Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangdong Jiaying Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 0.9% Return on Equity means Guangdong Jiaying Pharmaceutical Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 0.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM1.6%-0.7%
TTM1.6%YOY0.7%+0.9%
TTM1.6%5Y-0.2%+1.8%
5Y-0.2%10Y0.9%-1.1%

1.2. Operating Efficiency of Guangdong Jiaying Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guangdong Jiaying Pharmaceutical Co Ltd is operating .

  • Measures how much profit Guangdong Jiaying Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangdong Jiaying Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 6.1% means the company generated ¥0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 6.1%. The company is operating less efficient.
  • The TTM is 7.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.1%TTM7.7%-1.6%
TTM7.7%YOY6.8%+1.0%
TTM7.7%5Y1.9%+5.8%
5Y1.9%10Y1.1%+0.8%
1.2.2. Operating Ratio

Measures how efficient Guangdong Jiaying Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.23 means that the operating costs are ¥1.23 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 1.231. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.259. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.231TTM1.259-0.028
TTM1.259YOY1.230+0.029
TTM1.2595Y1.216+0.043
5Y1.21610Y0.766+0.450

1.3. Liquidity of Guangdong Jiaying Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guangdong Jiaying Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 13.15 means the company has ¥13.15 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 13.153. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.719. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.153TTM10.719+2.433
TTM10.719YOY7.328+3.391
TTM10.7195Y6.207+4.512
5Y6.20710Y3.271+2.936
1.3.2. Quick Ratio

Measures if Guangdong Jiaying Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangdong Jiaying Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 7.91 means the company can pay off ¥7.91 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 7.914. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.366. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.914TTM5.366+2.548
TTM5.366YOY2.203+3.163
TTM5.3665Y2.589+2.777
5Y2.58910Y2.639-0.050

1.4. Solvency of Guangdong Jiaying Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guangdong Jiaying Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangdong Jiaying Pharmaceutical Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.09 means that Guangdong Jiaying Pharmaceutical Co Ltd assets are financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.109. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.109-0.015
TTM0.109YOY0.130-0.021
TTM0.1095Y0.147-0.038
5Y0.14710Y0.133+0.015
1.4.2. Debt to Equity Ratio

Measures if Guangdong Jiaying Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangdong Jiaying Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 10.3% means that company has ¥0.10 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The MRQ is 0.103. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.123. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.103TTM0.123-0.019
TTM0.123YOY0.150-0.027
TTM0.1235Y0.175-0.052
5Y0.17510Y0.155+0.020

2. Market Valuation of Guangdong Jiaying Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangdong Jiaying Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guangdong Jiaying Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of 132.26 means the investor is paying ¥132.26 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The EOD is 124.448. Based on the earnings, the company is expensive. -2
  • The MRQ is 132.261. Based on the earnings, the company is expensive. -2
  • The TTM is 109.815. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD124.448MRQ132.261-7.814
MRQ132.261TTM109.815+22.447
TTM109.815YOY40.579+69.236
TTM109.8155Y219.376-109.562
5Y219.37610Y193.024+26.352
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The EOD is 73.875. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 78.514. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is -73.517. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD73.875MRQ78.514-4.638
MRQ78.514TTM-73.517+152.031
TTM-73.517YOY590.132-663.648
TTM-73.5175Y106.318-179.835
5Y106.31810Y53.159+53.159
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guangdong Jiaying Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 4.69 means the investor is paying ¥4.69 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangdong Jiaying Pharmaceutical Co Ltd:

  • The EOD is 4.408. Based on the equity, the company is fair priced.
  • The MRQ is 4.685. Based on the equity, the company is fair priced.
  • The TTM is 5.169. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.408MRQ4.685-0.277
MRQ4.685TTM5.169-0.484
TTM5.169YOY4.582+0.586
TTM5.1695Y4.569+0.600
5Y4.56910Y5.410-0.842
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangdong Jiaying Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0130.022-41%0.009+38%-0.001+111%0.023-43%
Book Value Per Share--1.4811.461+1%1.365+9%1.411+5%1.572-6%
Current Ratio--13.15310.719+23%7.328+79%6.207+112%3.271+302%
Debt To Asset Ratio--0.0940.109-14%0.130-28%0.147-36%0.133-29%
Debt To Equity Ratio--0.1030.123-16%0.150-31%0.175-41%0.155-33%
Dividend Per Share----0%0.000-100%0.001-100%0.006-100%
Eps--0.0130.023-43%0.009+38%-0.001+110%0.017-21%
Free Cash Flow Per Share--0.0220.037-40%0.013+74%0.027-19%0.027-19%
Free Cash Flow To Equity Per Share--0.0220.037-40%-0.003+114%0.014+56%0.014+56%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--0.764--------
Intrinsic Value_10Y_min--0.678--------
Intrinsic Value_1Y_max--0.114--------
Intrinsic Value_1Y_min--0.112--------
Intrinsic Value_3Y_max--0.314--------
Intrinsic Value_3Y_min--0.301--------
Intrinsic Value_5Y_max--0.480--------
Intrinsic Value_5Y_min--0.448--------
Market Cap3314040404.480-6%3522119511.0403834238170.880-8%3168131274.880+11%3272316637.700+8%4402722293.570-20%
Net Profit Margin--0.0560.072-22%0.033+67%-0.002+103%0.067-18%
Operating Margin--0.0610.077-21%0.068-9%0.019+225%0.011+455%
Operating Ratio--1.2311.259-2%1.230+0%1.216+1%0.766+61%
Pb Ratio4.408-6%4.6855.169-9%4.582+2%4.569+3%5.410-13%
Pe Ratio124.448-6%132.261109.815+20%40.579+226%219.376-40%193.024-31%
Price Per Share6.530-6%6.9407.555-8%6.243+11%6.447+8%8.675-20%
Price To Free Cash Flow Ratio73.875-6%78.514-73.517+194%590.132-87%106.318-26%53.159+48%
Price To Total Gains Ratio497.791-6%529.046503.595+5%106.869+395%626.918-16%461.650+15%
Quick Ratio--7.9145.366+47%2.203+259%2.589+206%2.639+200%
Return On Assets--0.0080.014-42%0.006+33%-0.001+108%0.009-6%
Return On Equity--0.0090.016-44%0.007+29%-0.002+122%0.009-3%
Total Gains Per Share--0.0130.022-41%0.010+34%-0.001+105%0.029-55%
Usd Book Value--104045883.602102620753.539+1%95887773.860+9%99104172.994+5%110406111.313-6%
Usd Book Value Change Per Share--0.0020.003-41%0.001+38%0.000+111%0.003-43%
Usd Book Value Per Share--0.2050.202+1%0.189+9%0.195+5%0.218-6%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.001-100%
Usd Eps--0.0020.003-43%0.001+38%0.000+110%0.002-21%
Usd Free Cash Flow--1552149.6132582970.763-40%890473.803+74%1439033.510+8%719516.755+116%
Usd Free Cash Flow Per Share--0.0030.005-40%0.002+74%0.004-19%0.004-19%
Usd Free Cash Flow To Equity Per Share--0.0030.005-40%0.000+114%0.002+56%0.002+56%
Usd Market Cap458663191.980-6%487461340.328530658562.850-8%438469368.443+11%452888622.658+8%609336765.430-20%
Usd Price Per Share0.904-6%0.9601.046-8%0.864+11%0.892+8%1.201-20%
Usd Profit--921397.5791611718.150-43%665773.122+38%-91171.501+110%1161675.332-21%
Usd Revenue--16582640.06121514737.937-23%20294879.256-18%19779698.850-16%18295537.690-9%
Usd Total Gains Per Share--0.0020.003-41%0.001+34%0.000+105%0.004-55%
 EOD+4 -4MRQTTM+11 -22YOY+27 -85Y+26 -910Y+13 -23

3.2. Fundamental Score

Let's check the fundamental score of Guangdong Jiaying Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15124.448
Price to Book Ratio (EOD)Between0-14.408
Net Profit Margin (MRQ)Greater than00.056
Operating Margin (MRQ)Greater than00.061
Quick Ratio (MRQ)Greater than17.914
Current Ratio (MRQ)Greater than113.153
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.103
Return on Equity (MRQ)Greater than0.150.009
Return on Assets (MRQ)Greater than0.050.008
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Guangdong Jiaying Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.417
Ma 20Greater thanMa 506.432
Ma 50Greater thanMa 1006.219
Ma 100Greater thanMa 2006.744
OpenGreater thanClose6.510
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets829,462
Total Liabilities77,686
Total Stockholder Equity751,777
 As reported
Total Liabilities 77,686
Total Stockholder Equity+ 751,777
Total Assets = 829,462

Assets

Total Assets829,462
Total Current Assets558,916
Long-term Assets270,547
Total Current Assets
Cash And Cash Equivalents 105,648
Short-term Investments 180,000
Net Receivables 156,291
Inventory 92,041
Other Current Assets 24,935
Total Current Assets  (as reported)558,916
Total Current Assets  (calculated)558,916
+/- 0
Long-term Assets
Property Plant Equipment 194,344
Intangible Assets 47,946
Other Assets 2,179
Long-term Assets  (as reported)270,547
Long-term Assets  (calculated)244,469
+/- 26,077

Liabilities & Shareholders' Equity

Total Current Liabilities42,494
Long-term Liabilities35,192
Total Stockholder Equity751,777
Total Current Liabilities
Accounts payable 10,360
Other Current Liabilities 27,881
Total Current Liabilities  (as reported)42,494
Total Current Liabilities  (calculated)38,241
+/- 4,253
Long-term Liabilities
Other Liabilities 35,192
Long-term Liabilities  (as reported)35,192
Long-term Liabilities  (calculated)35,192
+/- 0
Total Stockholder Equity
Common Stock507,510
Retained Earnings 122,408
Total Stockholder Equity (as reported)751,777
Total Stockholder Equity (calculated)629,918
+/- 121,859
Other
Capital Stock507,510
Common Stock Shares Outstanding 507,510
Net Invested Capital 751,777
Net Tangible Assets 703,831
Net Working Capital 516,421
Property Plant and Equipment Gross 194,344



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302006-12-31
> Total Assets 
120,051
122,008
129,837
245,478
235,215
226,489
230,241
235,240
235,432
237,756
241,428
253,330
257,646
297,469
287,472
300,872
306,474
301,100
306,097
306,549
309,254
306,570
308,604
314,248
309,344
297,878
320,716
919,003
948,903
970,354
1,018,289
1,035,284
1,014,052
1,009,239
1,004,231
1,047,997
1,030,254
1,036,541
1,055,936
1,099,254
1,086,379
1,101,463
1,087,078
876,610
853,534
868,924
857,048
889,559
880,253
964,216
969,809
855,938
822,180
825,013
836,554
808,440
800,964
811,271
824,797
807,338
790,019
782,742
806,327
846,651
831,191
821,986
829,462
829,462821,986831,191846,651806,327782,742790,019807,338824,797811,271800,964808,440836,554825,013822,180855,938969,809964,216880,253889,559857,048868,924853,534876,6101,087,0781,101,4631,086,3791,099,2541,055,9361,036,5411,030,2541,047,9971,004,2311,009,2391,014,0521,035,2841,018,289970,354948,903919,003320,716297,878309,344314,248308,604306,570309,254306,549306,097301,100306,474300,872287,472297,469257,646253,330241,428237,756235,432235,240230,241226,489235,215245,478129,837122,008120,051
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
369,305
404,478
363,316
402,300
409,636
409,263
382,967
437,151
455,277
434,520
434,745
456,610
478,317
489,673
478,988
477,935
508,157
557,433
548,051
545,526
558,916
558,916545,526548,051557,433508,157477,935478,988489,673478,317456,610434,745434,520455,277437,151382,967409,263409,636402,300363,316404,478369,3050000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
72,281
114,948
45,935
55,995
48,249
122,309
95,240
123,151
142,509
142,236
166,506
195,040
212,563
239,385
229,387
206,525
206,720
183,858
181,964
213,164
105,648
105,648213,164181,964183,858206,720206,525229,387239,385212,563195,040166,506142,236142,509123,15195,240122,30948,24955,99545,935114,94872,2810000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,261
50,000
60,000
180,000
180,00060,00050,00050,261000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
20,645
14,680
23,474
28,244
33,758
32,394
35,522
38,284
41,134
27,371
25,256
31,342
29,373
24,595
23,755
31,162
30,555
27,420
27,248
30,671
33,554
30,480
33,078
41,158
36,438
31,055
30,971
150,612
189,792
173,095
188,235
192,097
194,755
184,455
176,820
199,366
198,177
203,682
211,022
223,668
225,528
220,252
220,377
224,562
227,924
226,028
219,209
217,536
123,291
133,609
140,570
201,092
193,994
210,861
215,756
200,522
173,036
149,682
163,743
160,306
161,020
101,438
177,025
225,270
217,787
164,437
156,291
156,291164,437217,787225,270177,025101,438161,020160,306163,743149,682173,036200,522215,756210,861193,994201,092140,570133,609123,291217,536219,209226,028227,924224,562220,377220,252225,528223,668211,022203,682198,177199,366176,820184,455194,755192,097188,235173,095189,792150,61230,97131,05536,43841,15833,07830,48033,55430,67127,24827,42030,55531,16223,75524,59529,37331,34225,25627,37141,13438,28435,52232,39433,75828,24423,47414,68020,645
       Other Current Assets 
3,009
0
0
0
392
627
307
30,595
257
0
0
7,354
1,696
2,778
271
2,724
8,183
2,025
3,419
3,420
286
619
422
1,002
1,024
883
3,194
9,297
4,915
4,257
9,205
2,664
3,513
4,040
13,944
890
3,563
3,789
4,945
5,439
6,479
5,400
7,710
2,390
8,333
3,091
5,211
287
1,564
39,438
58,566
9,091
16,275
21,250
22,703
18,084
20,518
18,494
24,345
12,957
9,395
20,048
46,341
13,539
14,862
24,251
24,935
24,93524,25114,86213,53946,34120,0489,39512,95724,34518,49420,51818,08422,70321,25016,2759,09158,56639,4381,5642875,2113,0918,3332,3907,7105,4006,4795,4394,9453,7893,56389013,9444,0403,5132,6649,2054,2574,9159,2973,1948831,0241,0024226192863,4203,4192,0258,1832,7242712,7781,6967,3540025730,5953076273920003,009
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
516,937
561,916
560,173
446,676
439,213
387,861
381,278
373,920
366,219
354,661
346,480
317,665
311,031
304,807
298,169
289,218
283,140
276,461
270,547
270,547276,461283,140289,218298,169304,807311,031317,665346,480354,661366,219373,920381,278387,861439,213446,676560,173561,916516,937000000000000000000000000000000000000000000000000
       Property Plant Equipment 
46,393
55,708
52,715
52,784
53,242
64,559
63,409
74,345
87,733
106,237
121,932
131,877
154,155
153,587
153,789
159,599
162,960
163,839
157,991
155,868
152,752
154,582
148,840
149,895
143,907
149,204
147,779
230,778
212,046
222,979
232,598
244,976
246,090
246,423
253,276
275,138
270,728
267,462
264,106
261,329
262,729
270,462
265,707
264,988
262,273
257,960
254,545
252,153
247,782
242,867
243,784
255,559
250,942
251,890
246,703
245,780
240,140
233,802
229,049
224,189
219,116
0
209,771
203,703
200,109
198,245
194,344
194,344198,245200,109203,703209,7710219,116224,189229,049233,802240,140245,780246,703251,890250,942255,559243,784242,867247,782252,153254,545257,960262,273264,988265,707270,462262,729261,329264,106267,462270,728275,138253,276246,423246,090244,976232,598222,979212,046230,778147,779149,204143,907149,895148,840154,582152,752155,868157,991163,839162,960159,599153,789153,587154,155131,877121,932106,23787,73374,34563,40964,55953,24252,78452,71555,70846,393
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
360,919
120,787
120,787
120,787
120,787
120,787
120,787
120,787
120,787
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000120,787120,787120,787120,787120,787120,787120,787120,787360,919360,919360,919360,919360,919360,919360,919360,919360,919360,919360,919360,919360,919360,919360,9190000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,923
27,538
66,648
63,556
63,889
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000063,88963,55666,64827,53826,9230000000000000000000000000000000000000000000000
       Intangible Assets 
5,781
3,044
6,002
2,780
4,994
2,560
4,582
2,252
5,956
1,988
5,586
1,724
4,941
1,460
4,631
1,195
4,323
931
3,953
666
3,985
402
3,615
137
3,369
0
3,321
45,388
434,933
433,664
432,303
458,294
456,832
455,370
453,961
453,903
452,432
450,960
449,493
448,022
446,550
445,078
443,613
202,008
200,537
199,065
76,806
75,334
73,864
20,309
70,926
69,457
67,989
66,520
65,644
64,163
62,682
61,148
59,763
58,293
56,809
55,327
53,851
52,375
50,896
49,422
47,946
47,94649,42250,89652,37553,85155,32756,80958,29359,76361,14862,68264,16365,64466,52067,98969,45770,92620,30973,86475,33476,806199,065200,537202,008443,613445,078446,550448,022449,493450,960452,432453,903453,961455,370456,832458,294432,303433,664434,93345,3883,32103,3691373,6154023,9856663,9539314,3231,1954,6311,4604,9411,7245,5861,9885,9562,2524,5822,5604,9942,7806,0023,0445,781
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
516,937
561,916
560,173
3,425
1,974
1,974
248,677
88
88
0
0
0
0
0
0
1,548
1,482
0
0
001,4821,5480000008888248,6771,9741,9743,425560,173561,916516,937000000000000000000000000000000000000000000000000
> Total Liabilities 
37,424
29,343
29,724
32,853
18,067
6,757
7,376
8,895
6,446
5,630
5,097
11,905
12,074
48,453
41,301
42,401
40,741
42,643
45,950
36,040
39,223
38,673
37,073
36,170
28,872
18,574
32,266
109,346
122,822
148,941
178,020
171,938
136,602
114,041
99,309
118,297
92,844
90,898
105,818
114,382
93,671
106,758
108,827
126,799
95,267
107,714
90,212
104,207
86,423
164,964
163,737
192,771
157,338
164,739
173,640
125,434
110,193
124,079
137,296
122,854
103,000
89,664
99,584
118,233
90,587
76,867
77,686
77,68676,86790,587118,23399,58489,664103,000122,854137,296124,079110,193125,434173,640164,739157,338192,771163,737164,96486,423104,20790,212107,71495,267126,799108,827106,75893,671114,382105,81890,89892,844118,29799,309114,041136,602171,938178,020148,941122,822109,34632,26618,57428,87236,17037,07338,67339,22336,04045,95042,64340,74142,40141,30148,45312,07411,9055,0975,6306,4468,8957,3766,75718,06732,85329,72429,34337,424
   > Total Current Liabilities 
37,424
29,343
29,724
32,853
18,067
6,757
7,376
8,895
6,446
5,630
5,097
11,905
12,074
28,453
11,301
34,901
18,241
12,643
15,950
36,040
33,723
28,873
37,073
36,170
28,872
18,574
20,766
74,600
88,075
114,194
143,273
137,191
101,855
79,294
64,563
83,550
58,097
56,151
71,071
79,635
58,924
72,011
74,080
91,571
60,039
72,967
55,161
69,164
51,389
129,938
128,719
157,761
122,337
129,746
138,655
90,457
75,225
89,119
102,345
87,911
68,065
54,315
64,267
82,947
55,333
41,644
42,494
42,49441,64455,33382,94764,26754,31568,06587,911102,34589,11975,22590,457138,655129,746122,337157,761128,719129,93851,38969,16455,16172,96760,03991,57174,08072,01158,92479,63571,07156,15158,09783,55064,56379,294101,855137,191143,273114,19488,07574,60020,76618,57428,87236,17037,07328,87333,72336,04015,95012,64318,24134,90111,30128,45312,07411,9055,0975,6306,4468,8957,3766,75718,06732,85329,72429,34337,424
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,000
84,000
84,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000084,00084,00019,000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,000
84,000
84,000
96,781
90,000
75,000
75,000
20,164
15,153
31,105
31,105
31,105
21,057
0
0
0
0
0
0
00000021,05731,10531,10531,10515,15320,16475,00075,00090,00096,78184,00084,00019,000000000000000000000000000000000000000000000000000
       Accounts payable 
6,331
2,396
3,538
4,691
2,738
3,040
2,426
3,728
3,721
3,022
1,938
8,383
8,409
6,057
4,240
6,243
3,749
4,707
4,342
6,924
5,055
3,958
3,112
5,686
4,585
12,831
7,712
17,449
32,263
65,665
87,372
66,270
33,897
12,867
11,308
12,283
11,105
9,723
8,125
11,171
8,835
9,653
11,525
11,886
12,879
15,833
6,312
10,213
8,140
5,910
3,655
15,610
8,146
9,543
7,656
10,297
11,812
7,510
8,748
14,124
11,828
7,702
11,245
18,975
16,719
9,683
10,360
10,3609,68316,71918,97511,2457,70211,82814,1248,7487,51011,81210,2977,6569,5438,14615,6103,6555,9108,14010,2136,31215,83312,87911,88611,5259,6538,83511,1718,1259,72311,10512,28311,30812,86733,89766,27087,37265,66532,26317,4497,71212,8314,5855,6863,1123,9585,0556,9244,3424,7073,7496,2434,2406,0578,4098,3831,9383,0223,7213,7282,4263,0402,7384,6913,5382,3966,331
       Other Current Liabilities 
9,093
4,947
4,186
6,162
5,329
3,717
4,950
5,167
2,725
2,608
3,159
3,522
3,665
12,396
7,061
13,658
14,492
7,936
11,608
6,616
6,168
17,415
15,411
11,934
11,237
5,743
9,554
42,151
31,512
24,229
26,701
36,922
39,258
30,727
27,954
41,168
23,493
22,928
29,447
48,564
30,088
32,358
32,555
39,686
25,160
27,134
24,131
17,573
22,164
31,648
39,435
29,954
21,510
40,227
52,020
49,140
45,887
41,151
58,912
26,163
32,914
5,197
48,893
42,909
35,749
22,146
27,881
27,88122,14635,74942,90948,8935,19732,91426,16358,91241,15145,88749,14052,02040,22721,51029,95439,43531,64822,16417,57324,13127,13425,16039,68632,55532,35830,08848,56429,44722,92823,49341,16827,95430,72739,25836,92226,70124,22931,51242,1519,5545,74311,23711,93415,41117,4156,1686,61611,6087,93614,49213,6587,06112,3963,6653,5223,1592,6082,7255,1674,9503,7175,3296,1624,1864,9479,093
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,035
35,026
35,018
35,010
35,001
34,993
34,985
34,976
34,968
34,960
34,951
34,943
34,935
35,349
35,317
35,286
35,254
35,223
35,192
35,19235,22335,25435,28635,31735,34934,93534,94334,95134,96034,96834,97634,98534,99335,00135,01035,01835,02635,035000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
482
482
0
35,051
35,043
35,035
35,026
35,018
35,010
35,001
34,993
34,985
34,976
34,968
34,960
34,951
34,943
34,935
0
35,317
0
35,254
35,223
35,192
35,19235,22335,254035,317034,93534,94334,95134,96034,96834,97634,98534,99335,00135,01035,01835,02635,03535,04335,05104824820000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000013260000000000000000000000000000000000000000000000
> Total Stockholder Equity
82,627
92,664
100,114
212,624
217,148
219,732
222,865
226,345
228,986
232,126
236,330
241,424
245,572
249,016
246,172
258,471
265,732
258,457
260,146
270,510
270,031
267,896
271,531
278,078
280,472
279,303
288,450
809,657
826,081
821,413
840,270
863,346
877,450
895,198
904,921
929,701
937,410
945,643
950,118
984,873
992,708
994,705
978,251
749,811
758,267
761,211
766,836
785,352
793,829
799,252
806,072
663,168
664,842
660,274
662,914
683,006
690,770
687,192
687,501
684,483
687,019
693,078
706,743
728,418
740,604
745,119
751,777
751,777745,119740,604728,418706,743693,078687,019684,483687,501687,192690,770683,006662,914660,274664,842663,168806,072799,252793,829785,352766,836761,211758,267749,811978,251994,705992,708984,873950,118945,643937,410929,701904,921895,198877,450863,346840,270821,413826,081809,657288,450279,303280,472278,078271,531267,896270,031270,510260,146258,457265,732258,471246,172249,016245,572241,424236,330232,126228,986226,345222,865219,732217,148212,624100,11492,66482,627
   Common Stock
61,500
61,500
61,500
82,000
82,000
82,000
82,000
82,000
82,000
82,000
82,000
82,000
82,000
82,000
164,000
164,000
164,000
205,000
205,000
205,000
205,000
205,000
205,000
205,000
205,000
205,000
205,000
253,755
253,755
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
507,510
0
507,510
0
507,510
507,510
507,510
507,510507,510507,5100507,5100507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510507,510253,755253,755205,000205,000205,000205,000205,000205,000205,000205,000205,000205,000164,000164,000164,00082,00082,00082,00082,00082,00082,00082,00082,00082,00082,00082,00061,50061,50061,500
   Retained Earnings 
17,385
27,422
34,871
39,362
43,886
46,469
49,603
51,711
54,351
57,492
61,696
65,282
69,430
72,874
45,429
55,204
62,466
14,190
15,879
23,693
23,215
21,080
24,714
30,096
32,491
31,322
40,469
158,942
195,165
190,497
209,353
232,429
246,533
264,282
274,005
298,784
306,494
314,727
319,201
353,956
361,792
363,789
347,335
118,894
127,351
130,294
135,920
154,436
135,690
141,112
147,932
32,251
33,925
29,357
31,998
52,090
59,854
56,275
56,584
53,567
56,103
34,939
75,826
70,279
109,688
115,750
122,408
122,408115,750109,68870,27975,82634,93956,10353,56756,58456,27559,85452,09031,99829,35733,92532,251147,932141,112135,690154,436135,920130,294127,351118,894347,335363,789361,792353,956319,201314,727306,494298,784274,005264,282246,533232,429209,353190,497195,165158,94240,46931,32232,49130,09624,71421,08023,21523,69315,87914,19062,46655,20445,42972,87469,43065,28261,69657,49254,35151,71149,60346,46943,88639,36234,87127,42217,385
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue621,813
Cost of Revenue-221,761
Gross Profit400,053400,053
 
Operating Income (+$)
Gross Profit400,053
Operating Expense-566,113
Operating Income55,700-166,061
 
Operating Expense (+$)
Research Development14,990
Selling General Administrative290,732
Selling And Marketing Expenses-
Operating Expense566,113305,722
 
Net Interest Income (+$)
Interest Income4,082
Interest Expense--
Other Finance Cost-3,097
Net Interest Income984
 
Pretax Income (+$)
Operating Income55,700
Net Interest Income984
Other Non-Operating Income Expenses-
Income Before Tax (EBT)52,55655,700
EBIT - interestExpense = 0
46,581
46,581
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-52,556
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax52,556
Tax Provision-5,975
Net Income From Continuing Ops46,58146,581
Net Income46,581
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--984
 

Technical Analysis of Guangdong Jiaying Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangdong Jiaying Pharmaceutical Co Ltd. The general trend of Guangdong Jiaying Pharmaceutical Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangdong Jiaying Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangdong Jiaying Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.87 < 6.9 < 7.04.

The bearish price targets are: 6.18 > 5.61 > 4.83.

Tweet this
Guangdong Jiaying Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangdong Jiaying Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangdong Jiaying Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangdong Jiaying Pharmaceutical Co Ltd. The current macd is 0.10728375.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangdong Jiaying Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Guangdong Jiaying Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Guangdong Jiaying Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guangdong Jiaying Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangdong Jiaying Pharmaceutical Co Ltd. The current adx is 25.73.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Guangdong Jiaying Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Guangdong Jiaying Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangdong Jiaying Pharmaceutical Co Ltd. The current sar is 6.79466879.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangdong Jiaying Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangdong Jiaying Pharmaceutical Co Ltd. The current rsi is 54.42. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Guangdong Jiaying Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangdong Jiaying Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangdong Jiaying Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guangdong Jiaying Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangdong Jiaying Pharmaceutical Co Ltd. The current cci is 35.36.

Guangdong Jiaying Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangdong Jiaying Pharmaceutical Co Ltd. The current cmo is 8.15680655.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Guangdong Jiaying Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangdong Jiaying Pharmaceutical Co Ltd. The current willr is -58.73015873.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Guangdong Jiaying Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Guangdong Jiaying Pharmaceutical Co Ltd Daily Williams %R ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangdong Jiaying Pharmaceutical Co Ltd.

Guangdong Jiaying Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangdong Jiaying Pharmaceutical Co Ltd. The current atr is 0.24552018.

Guangdong Jiaying Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangdong Jiaying Pharmaceutical Co Ltd. The current obv is 468,021,632.

Guangdong Jiaying Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangdong Jiaying Pharmaceutical Co Ltd. The current mfi is 55.67.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Guangdong Jiaying Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartGuangdong Jiaying Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangdong Jiaying Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Guangdong Jiaying Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangdong Jiaying Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.417
Ma 20Greater thanMa 506.432
Ma 50Greater thanMa 1006.219
Ma 100Greater thanMa 2006.744
OpenGreater thanClose6.510
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guangdong Jiaying Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guangdong Jiaying Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangdong Jiaying Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangdong Jiaying Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guangdong Jiaying Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangdong Jiaying Pharmaceutical Co Ltd.

Receive notifications about Guangdong Jiaying Pharmaceutical Co Ltd in your mailbox!